|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ilson DH: Adjuvant treatment for gastric
cancer: Too much is not enough. Lancet Oncol. 15:788–789. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bagcchi S: Radiotherapy for testicular
cancer increases gastric cancer risk. Lancet Oncol. 15:e5932014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Konishi H, Ichikawa D, Komatsu S, Shiozaki
A, Tsujiura M, Takeshita H, Morimura R, Nagata H, Arita T,
Kawaguchi T, et al: Detection of gastric cancer-associated
microRNAs on microRNA microarray comparing pre- and post-operative
plasma. Br J Cancer. 106:740–747. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zirtiloglu A, Cil I, Mehmet VF and Tural
D: What are the optimal treatment modalities according to age group
in gastric cancer patients? J Buon. 22:312–319. 2017.PubMed/NCBI
|
|
7
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xia Y, Yan Z, Wan Y, Wei S, Bi Y, Zhao J,
Liu J, Liao DJ and Huang H: Knockdown of long noncoding RNA GHET1
inhibits cellcycle progression and invasion of gastric cancer
cells. Mol Med Rep. 18:3375–3381. 2018.PubMed/NCBI
|
|
10
|
Lv Z, Zhang Y, Yu X, Lin Y and Ge Y: The
function of long non-coding RNA MT1JP in the development and
progression of gastric cancer. Pathol Res Pract. 214:1218–1223.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu C, Ma J, Li Y, Zhang Y and Da M: Low
expression of long noncoding RNA MT1JP is associated with poor
overall survival in gastric cancer patients: Protocol for
meta-analysis. Medicine (Baltimore). 97:e103942018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shi X, Wang X and Hua Y: LncRNA GACAT1
promotes gastric cancer cell growth, invasion and migration by
regulating miR-149-mediated of ZBTB2 and SP1. J Cancer.
9:3715–3722. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J
and Fang G: Up-regulated long non-coding RNA H19 contributes to
proliferation of gastric cancer cells. Febs J. 279:3159–3165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu G, Xiang T, Wu QF and Wang WX:
Curcumin suppresses the proliferation of gastric cancer cells by
downregulating H19. Oncol Lett. 12:5156–5162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y
and Fang G: Long noncoding RNA CCAT1, which could be activated by
c-Myc, promotes the progression of gastric carcinoma. J Cancer Res
Clin Oncol. 139:437–445. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Henriksen J, Stabell M, Meza-Zepeda LA,
Lauvrak SA, Kassem M and Myklebost O: Identification of target
genes for wild type and truncated HMGA2 in mesenchymal stem-like
cells. BMC Cancer. 10:3292010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun T, Zhao N, Zhao XL, Gu Q, Zhang SW,
Che N, Wang XH, Du J, Liu YX and Sun BC: Expression and functional
significance of Twist1 in hepatocellular carcinoma: Its role in
vasculogenic mimicry. Hepatology. 51:545–556. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wagenblast E, Soto M, Gutierrez-Angel S,
Hartl CA, Gable AL, Maceli AR, Erard N, Williams AM, Kim SY,
Dickopf S, et al: A model of breast cancer heterogeneity reveals
vascular mimicry as a driver of metastasis. Nature. 520:358–362.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Williamson SC, Metcalf RL, Trapani F,
Mohan S, Antonello J, Abbott B, Leong HS, Chester CP, Simms N,
Polanski R, et al: Vasculogenic mimicry in small cell lung cancer.
Nat Commun. 7:133222016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang JY, Sun T, Zhao XL, Zhang SW, Zhang
DF, Gu Q, Wang XH, Zhao N, Qie S and Sun BC: Functional
significance of VEGF-a in human ovarian carcinoma: Role in
vasculogenic mimicry. Cancer Biol Ther. 7:758–766. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Baeten CI, Hillen F, Pauwels P, de Bruine
AP and Baeten CG: Prognostic role of vasculogenic mimicry in
colorectal cancer. Dis Colon Rectum. 52:2028–2035. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhong X, Liu X, Li Y, Cheng M, Wang W,
Tian K, Mu L, Zeng T, Liu Y, Jiang X, et al: HMGA2 sustains
self-renewal and invasiveness of glioma-initiating cells.
Oncotarget. 7:44365–44380. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fujikane R, Komori K, Sekiguchi M and
Hidaka M: Function of high-mobility group A proteins in the DNA
damage signaling for the induction of apoptosis. Sci Rep.
6:317142016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu H, Lim HH, Tjokro NO, Sathiyanathan P,
Natarajan S, Chew TW, Klonisch T, Goodman SD, Surana U and Droge P:
Chaperoning HMGA2 protein protects stalled replication forks in
stem and cancer cells. Cell Rep. 6:684–697. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tan EJ, Thuault S, Caja L, Carletti T,
Heldin CH and Moustakas A: Regulation of transcription factor twist
expression by the DNA architectural protein high mobility group A2
during epithelial-to-mesenchymal transition. J Biol Chem.
287:7134–7145. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tan EJ, Kahata K, Idas O, Thuault S,
Heldin CH and Moustakas A: The high mobility group A2 protein
epigenetically silences the Cdh1 gene during
epithelial-to-mesenchymal transition. Nucleic Acids Res.
43:162–178. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Y, Zhao Z, Xu C, Zhou Z, Zhu Z and You
T: HMGA2 induces transcription factor Slug expression to promote
epithelial-to-mesenchymal transition and contributes to colon
cancer progression. Cancer Lett. 355:130–140. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Singh I, Mehta A, Contreras A, Boettger T,
Carraro G, Wheeler M, Cabrera-Fuentes HA, Bellusci S, Seeger W,
Braun T and Barreto G: Hmga2 is required for canonical WNT
signaling during lung development. BMC Biol. 12:212014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li T, Yang XD, Ye CX, Shen ZL, Yang Y,
Wang B, Guo P, Gao ZD, Ye YJ, Jiang KW and Wang S: Long noncoding
RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and
tumor progression by upregulating the expression of high mobility
group AT-hook 2 (HMGA2) gene. Cell Cycle. 16:224–231. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu C, Ren L, Wang Y, Liu Y and Xiao J:
The interaction between RACK1 and WEE1 regulates the growth of
gastric cancer cell line HGC27. Oncol Lett. 14:4784–4792. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kawai S, Kato S, Imai H, Okada Y and
Ishioka C: Suppression of FUT1 attenuates cell proliferation in the
HER2-overexpressing cancer cell line NCI-N87. Oncol Rep. 29:13–20.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Motoyama K, Inoue H, Nakamura Y, Uetake H,
Sugihara K and Mori M: Clinical significance of high mobility group
A2 in human gastric cancer and its relationship to let-7 microRNA
family. Clin Cancer Res. 14:2334–2340. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xia YY, Yin L, Tian H, Guo WJ, Jiang N,
Jiang XS, Wu J, Chen M, Wu JZ and He X: HMGA2 is associated with
epithelial-mesenchymal transition and can predict poor prognosis in
nasopharyngeal carcinoma. Onco Targets Ther. 8:169–176. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xia YY, Yin L, Jiang N, Guo WJ, Tian H,
Jiang XS, Wu J, Chen M, Wu JZ and He X: Downregulating HMGA2
attenuates epithelial-mesenchymal transition-induced invasion and
migration in nasopharyngeal cancer cells. Biochem Biophys Res
Commun. 463:357–363. 2015. View Article : Google Scholar : PubMed/NCBI
|
